NASDAQ · Biotechnology

MIST (MIST) Stock

$1.13 -2.59% NASDAQ: MIST Healthcare

Valuation

MetricValue
Price$1.13
Market Cap$97.05M
P/E Ratio-2.00
P/B Ratio3.07
P/S Ratio72.70
EPS (TTM)$-0.75
52-Week High$3.06
52-Week Low$1.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-150.00%
ROA-55.26%
ROCE-147.62%
Gross Margin-3100.00%
Operating Margin-3100.00%
Net Margin-38.32%
Debt/Equity3.81
Current Ratio8.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$15.0M$5.0M$1.0M$0$2.0M
Operating Profit$-43.0M$-60.0M$-61.0M$-42.0M$-62.0M
Net Profit$-43.0M$-58.0M$-60.0M$-42.0M$-63.0M
EPS$-1.02$-1.35$-1.39$-0.67$-0.75
Op Margin-287.1%-1192.8%-6109.8%—-4041.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$120.0M$74.0M$75.0M$75.0M$114.0M
Total Liabilities$7.0M$8.0M$58.0M$62.0M$72.0M
Cash$114.0M$8.0M$14.0M$25.0M$73.0M
Borrowings$1.0M$2.0M$52.0M$55.0M$58.0M

Latest News

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 3, 2026 Alpha Cognition Elects Robert Wills as Board Chairman MT Newswires · Jun 23, 2026 Milestone (MIST) Q1 2026 Earnings Transcript Motley Fool · Jun 1, 2026 Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer GlobeNewswire · May 21, 2026 Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability Simply Wall St. · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-33.0M$-52.0M$-46.0M$-29.0M$-49.0M
Investing Cash Flow$70.0M$-57.0M$5.0M$8.0M$11.0M
Financing Cash Flow$5.0M$0$-2.0M$5.0M$0
Net Cash Flow$42.0M$-107.0M$6.0M$12.0M$48.0M
Free Cash Flow$-33.0M$-53.0M$-47.0M$-29.0M$-49.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-39.50%
Quick Ratio9.09
Interest Coverage-15.50
Return 1Y-13.18%
Return 3Y-63.49%
Return 5Y-76.25%

Ownership

Insiders Held0.70%
Institutions Held34.69%
Institutions Float Held34.93%
Institutional HolderSharesReport Date
RTW Investments LP6,331,0012026-03-31
Propel Bio Management, LLC4,118,3212026-03-31
Two Sigma Investments, LP2,317,1762026-03-31
Goldman Sachs Group Inc2,000,0252026-03-31
Marshall Wace LLP1,944,5302026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APLTApplied Therapeutics, Inc. $0.10 +0.00% -0.24 $14.86M 0.00%
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
CRDF $0.81 -2.98% -2.58 $53.22M 0.00%
CYBNCybin Inc. $8.28 +1.22% -1.67 $413.02M 0.00%
ELTXElicio Therapeutics, Inc. $3.01 +0.17% -1.27 $57.29M 0.00%

About MIST

MIST is led by CEO Joseph G. Oliveto, publicly traded since 2019.

MIST stock trades at $1.13 with a market capitalization of $97.05M. The stock is valued at a price-to-earnings (P/E) ratio of -2.00, price-to-book of 3.07, price-to-sales of 72.70. Over the past 52 weeks the stock has ranged between $1.00 and $3.06, and currently trades 63.1% below its 52-week high.

On profitability, MIST generates a return on equity (ROE) of -150.00%, return on capital employed of -147.62%, an operating margin of -3100.00%, a net profit margin of -38.32%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides